🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter study will enroll approximately 185 participants with meta...
Status
Completed
Location
ImClone Investigational Site
Start Date
2008-07
Trial ID
NCT00668148
This randomized phase II trial studies cisplatin and etoposide to see how w...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2009-07-16
Trial ID
NCT00887159
Treatments Being Tested
This randomized phase II trial is studying bicalutamide, goserelin, or leup...
Status
Completed
Location
Fairbanks Memorial Hospital
Start Date
2010-12
Trial ID
NCT01120236
This phase I trial studies the side effects and best dose of cixutumumab wh...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2010-10
Trial ID
NCT01204476
Treatments Being Tested
The purpose of this study is to determine whether IMC-A12 or IMC-1121B (ram...
Status
Completed
Location
ImClone Investigational Site
Start Date
2008-08
Trial ID
NCT00683475
Treatments Being Tested
This phase II trial studies how well giving cixutumumab works in treating p...
Status
Completed
Location
Thomas Jefferson University Hospital
Start Date
2011-08
Trial ID
NCT01413191
Treatments Being Tested
Determine the 6-month progression free survival (PFS) rate associated with ...
Status
Completed
Location
ImClone Investigational Site
Start Date
2009-02
Trial ID
NCT00781911
Treatments Being Tested
This randomized phase I/II trial is studying the side effects and best dose...
Status
Completed
Location
NEA Baptist Memorial Hospital
Start Date
2008-03
Trial ID
NCT00617708
Treatments Being Tested
The primary purpose of this study is to evaluate the hypothesis that cixutu...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-04
Trial ID
NCT01232452
Treatments Being Tested
This randomized phase I/II trial is studying the side effects and best dose...
Status
Completed
Location
University of Colorado
Start Date
2008-10
Trial ID
NCT00778167
Treatments Being Tested